Linda E. Gustavson

945 total citations
23 papers, 722 citations indexed

About

Linda E. Gustavson is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Linda E. Gustavson has authored 23 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pharmacology. Recurrent topics in Linda E. Gustavson's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Linda E. Gustavson is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Linda E. Gustavson collaborates with scholars based in United States, United Kingdom and Germany. Linda E. Gustavson's co-authors include H. Mengel, Leslie Z. Benet, C. Locke, Anthony Edmonds, Tawakol A. El‐Shourbagy, Jiang Qian, Dennis W. Schneck, Sou-Yie Chu, Ramanuj Achari and Kenneth W. Sommerville and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and The American Journal of Medicine.

In The Last Decade

Linda E. Gustavson

23 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda E. Gustavson United States 17 285 284 195 125 119 23 722
Sunny Chapel United States 16 164 0.6× 162 0.6× 134 0.7× 67 0.5× 100 0.8× 45 991
M. L. Mashford Australia 16 148 0.5× 169 0.6× 80 0.4× 163 1.3× 65 0.5× 39 867
Arun Swaminathan United States 10 150 0.5× 351 1.2× 174 0.9× 25 0.2× 155 1.3× 21 994
Shean‐Sheng Wang United States 12 219 0.8× 214 0.8× 89 0.5× 33 0.3× 77 0.6× 17 498
Kent E. Opheim United States 17 56 0.2× 405 1.4× 138 0.7× 43 0.3× 81 0.7× 46 991
Georges Olive France 14 127 0.4× 265 0.9× 40 0.2× 50 0.4× 75 0.6× 21 608
M. René Bouw United Kingdom 15 167 0.6× 235 0.8× 56 0.3× 107 0.9× 231 1.9× 16 741
Joelle Campestrini United States 16 74 0.3× 96 0.3× 272 1.4× 92 0.7× 196 1.6× 29 776
J.F. Horga Spain 17 60 0.2× 88 0.3× 92 0.5× 149 1.2× 63 0.5× 47 729
Dolly A. Parasrampuria United States 15 215 0.8× 66 0.2× 57 0.3× 113 0.9× 104 0.9× 31 922

Countries citing papers authored by Linda E. Gustavson

Since Specialization
Citations

This map shows the geographic impact of Linda E. Gustavson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda E. Gustavson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda E. Gustavson more than expected).

Fields of papers citing papers by Linda E. Gustavson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda E. Gustavson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda E. Gustavson. The network helps show where Linda E. Gustavson may publish in the future.

Co-authorship network of co-authors of Linda E. Gustavson

This figure shows the co-authorship network connecting the top 25 collaborators of Linda E. Gustavson. A scholar is included among the top collaborators of Linda E. Gustavson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda E. Gustavson. Linda E. Gustavson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gustavson, Linda E., David Burt, Ramanuj Achari, et al.. (2006). Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects. Clinical Therapeutics. 28(3). 373–387. 22 indexed citations
2.
Gustavson, Linda E., et al.. (2005). The Effects of Multiple Doses of Fenofibrate on the Pharmacokinetics of Pravastatin and Its 3α‐Hydroxy Isomeric Metabolite. The Journal of Clinical Pharmacology. 45(8). 947–953. 25 indexed citations
3.
Gustavson, Linda E., Richard Bertz, Ann Hsu, et al.. (2000). Assessment of the bioequivalence and food effects for liquid and soft elastic capsule co-formulations of ABT-378/ritonavir in healthy subjects. 40. 338. 8 indexed citations
4.
Pan, Wei‐Jian, Linda E. Gustavson, Ramanuj Achari, et al.. (2000). Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(3). 316–323. 75 indexed citations
5.
Gustavson, Linda E., et al.. (1998). Lack of a Clinically Significant Pharmacokinetic Drug Interaction Between Tiagabine and Valproate. American Journal of Therapeutics. 5(2). 73–80. 16 indexed citations
6.
Carr, Robert, Anthony Edmonds, Harry Shi, et al.. (1998). Steady-State Pharmacokinetics and Electrocardiographic Pharmacodynamics of Clarithromycin and Loratadine after Individual or Concomitant Administration. Antimicrobial Agents and Chemotherapy. 42(5). 1176–1180. 28 indexed citations
7.
Gustavson, Linda E., Allen Cato, Samuel W. Boellner, et al.. (1998). Lack of Pharmacokinetic Drug Interactions Between Tiagabine and Carbamazepine or Phenytoin. American Journal of Therapeutics. 5(1). 9–16. 13 indexed citations
8.
Samara, Emil, Linda E. Gustavson, Tawakol A. El‐Shourbagy, et al.. (1998). Population Analysis of the Pharmacokinetics of Tiagabine in Patients with Epilepsy. Epilepsia. 39(8). 868–873. 20 indexed citations
9.
Cato, Allen, et al.. (1998). Effect of Renal Impairment on the Pharmacokinetics and Tolerability of Tiagabine. Epilepsia. 39(1). 43–47. 20 indexed citations
10.
Lau, Alan H., et al.. (1997). Pharmacokinetics and Safety of Tiagabine in Subjects with Various Degrees of Hepatic Function. Epilepsia. 38(4). 445–451. 47 indexed citations
11.
Gustavson, Linda E., Samuel W. Boellner, G. Richard Granneman, et al.. (1997). A single‐dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures. Neurology. 48(4). 1032–1036. 48 indexed citations
12.
So, Elson L., Nina M. Graves, Ilo E. Leppik, et al.. (1995). Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs. Epilepsy Research. 22(3). 221–226. 42 indexed citations
13.
Gustavson, Linda E., et al.. (1995). Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrobial Agents and Chemotherapy. 39(9). 2078–2083. 110 indexed citations
14.
Gustavson, Linda E. & H. Mengel. (1995). Pharmacokinetics of Tiagabine, a γ‐Aminobutyric Acid‐Uptake Inhibitor, in Healthy Subjects After Single and Multiple Doses. Epilepsia. 36(6). 605–611. 78 indexed citations
15.
Gustavson, Linda E. & Leslie Z. Benet. (1994). Menopause: Pharmacodynamics and pharmacokinetics. Experimental Gerontology. 29(3-4). 437–444. 16 indexed citations
16.
Gustavson, Linda E. & Sou-Yie Chu. (1992). High-performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 574(2). 313–318. 36 indexed citations
17.
Gustavson, Linda E., et al.. (1990). The clinical pharmacokinetics of single doses of estazolam. The American Journal of Medicine. 88(3). S2–S5. 17 indexed citations
18.
Tominack, Rebecca L., Robert J. Wills, Linda E. Gustavson, & Frederick G. Hayden. (1988). Multiple-dose pharmacokinetics of rimantadine in elderly adults. Antimicrobial Agents and Chemotherapy. 32(12). 1813–1819. 11 indexed citations
19.
Gustavson, Linda E., Udo F. Legler, & Leslie Z. Benet. (1986). Impairment of Prednisolone Disposition in Women Taking Oral Contraceptives or Conjugated Estrogens*. The Journal of Clinical Endocrinology & Metabolism. 62(1). 234–237. 35 indexed citations
20.
Gustavson, Linda E. & Leslie Z. Benet. (1985). The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users. Journal of Pharmacokinetics and Biopharmaceutics. 13(6). 561–569. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunny Chapel Breakdown of academic impact, for papers by M. L. Mashford Breakdown of academic impact, for papers by Arun Swaminathan Breakdown of academic impact, for papers by Shean‐Sheng Wang Breakdown of academic impact, for papers by Kent E. Opheim Breakdown of academic impact, for papers by Georges Olive Breakdown of academic impact, for papers by M. René Bouw Breakdown of academic impact, for papers by Joelle Campestrini Breakdown of academic impact, for papers by J.F. Horga Breakdown of academic impact, for papers by Dolly A. Parasrampuria
Rankless by CCL
2026